Tissue Science to be acquired by Covidien for £36mm

20 Mar 2008

Covidien and one of its subsidiaries have agreed to acquire publicly traded UK biomaterials developer Tissue Science Laboratories.

Biotechnology
Medical Devices
Medical Devices
- Biomaterials
- Implantable Devices
- Surgical Equipment & Devices

Already a Biomedtracker subscriber? You have access to the full deal record through your subscription

Want to become a subscriber? Subscribers get more deal details, updates, deal financials and deal products.

Questions?

Please contact Sales at: (212) 520-2765 or email [email protected]

Related Companies

Tissue Science to be acquired by Covidien for £36mm

All set! This article has been sent to my@email.address.

All fields are required. For multiple recipients, separate email addresses with a semicolon.

DCD.EmailPopout.Notice